Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
18 Feb 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212604
20 Aug 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214178
20 Aug 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214178
09 Dec 2020
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-9-2020-1607497312.pdf
04 Mar 2020
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210129
09 Jan 2020
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208797
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUPROPION HYDROCHLORIDE
Dosage Strength : 75MG
Packaging :
Approval Date : 2000-10-10
Application Number : 75613
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BUPROPION HYDROCHLORIDE
Dosage Strength : 100MG
Packaging :
Approval Date : 2000-10-10
Application Number : 75613
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET, DELAYED RELEASE;...
Brand Name : DIVALPROEX SODIUM
Dosage Strength : EQ 500MG VALPROIC ACID
Packaging :
Approval Date : 2008-07-29
Application Number : 78290
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET, DELAYED RELEASE;...
Brand Name : DIVALPROEX SODIUM
Dosage Strength : EQ 125MG VALPROIC ACID
Packaging :
Approval Date : 2008-07-29
Application Number : 78290
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET, DELAYED RELEASE;...
Brand Name : DIVALPROEX SODIUM
Dosage Strength : EQ 250MG VALPROIC ACID
Packaging :
Approval Date : 2008-07-29
Application Number : 78290
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : CREAM;TOPICAL
Brand Name : FLUOCINOLONE ACETONIDE
Dosage Strength : 0.025%
Packaging :
Approval Date : 1982-12-16
Application Number : 88045
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : GABAPENTIN
Dosage Strength : 800MG
Packaging :
Approval Date : 2006-07-06
Application Number : 76877
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : GABAPENTIN
Dosage Strength : 600MG
Packaging :
Approval Date : 2006-07-06
Application Number : 76877
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : MECLIZINE HYDROCHLORIDE
Dosage Strength : 25MG
Packaging :
Approval Date : 1989-05-22
Application Number : 84092
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : METHYLPREDNISOLONE
Dosage Strength : 4MG
Packaging :
Approval Date : 1982-01-01
Application Number : 87341
Regulatory Info : DISCN
Registration Country : USA
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?